New SEC Form D filing
Sensible Biotechnologies, Inc., 2026-09-02
A new SEC Form D private-offering notice from Oxford, Oxfordshire, a $15,000,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Developer of a cell based platform for cost efficient, scalable manufacturing of high quality mRNA for therapeutics and vaccines
Filed 7 days agoFiled to raise $15,000,000First money in 2026-08-17Raised so far $13,518,941HQ (as filed) Oxford, OxfordshireSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Non-US principal office
Source linked the Form D on EDGAR↗Website verified sensible.bio↗Named in the filing 4 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Aclarity Genomics, Inc., 2026-09-02, $4.6M, Morrisville, NC
- Telemachus Therapeutics, Inc., 2026-09-02, $1.5M, Pittsburgh, PA
- Agen Genomics, Inc., 2026-09-02, $1.5M, Escondido, CA
- Voxcell BioInnovation Inc., 2026-09-01, $2.2M, Victoria, BC, Canada
- Plowshare Therapies LLC, 2026-08-31, $6.7M, Lancaster, PA
- StrataBio Inc., 2026-08-31, $500K, Tallahassee, FL
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.